Save your place

Sign in to WhoBought

Please try again later.

AN2 Therapeutics, Inc. (ANTX) institutional ownership

Latest close $4.89 Jul 22, 2026
Market cap$139M 52-week range SectorHealthcare
Funds holding · Q1 2026
53
reported ANTX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
36 buyers · 17 sellers

AN2 Therapeutics, Inc. (ANTX) price and institutional activity

Dates

Q1 2026

$0 bought by 36 investors
Vivo Capital, LLCCommodore Capital LP +34 more
$0 sold by 17 investors
Pfizer IncPeapod Lane Capital LLC +15 more
Bought Sold Totals per quarter; hover a bar for the names.

AN2 Therapeutics, Inc. (ANTX) institutional activity · 53

Investor Type Est. change Change Δ Own Date
Vivo Capital, LLC · New
Change +3.2M Date Q1 2026
Vivo Capital, LLC New· Q1 2026 +3.2M Q1 2026
Commodore Capital LP · New
Change +2.3M Date Q1 2026
Commodore Capital LP New· Q1 2026 +2.3M Q1 2026
Millennium Management LLC · Added
Change +2.1M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +2.1M Q1 2026
Spruce Street Capital LP · New
Change +1.7M Date Q1 2026
Spruce Street Capital LP New· Q1 2026 +1.7M Q1 2026
Adage Capital Partners Gp, L.L.C. · New
Change +1.0M Date Q1 2026
Adage Capital Partners Gp, L.L.C. New· Q1 2026 +1.0M Q1 2026
Woodline Partners LP · Added
Change +848K Date Q1 2026
Woodline Partners LP Added· Q1 2026 +848K Q1 2026
Boxer Capital Management, LLC · New
Change +749K Date Q1 2026
Boxer Capital Management, LLC New· Q1 2026 +749K Q1 2026
Pfizer Inc · Exited
Change −715K Δ Own −100.0% Date Q1 2026
Pfizer Inc Exited· Q1 2026 −715K −100.0% Q1 2026
Ameriprise Financial Inc · New
Change +696K Date Q1 2026
Ameriprise Financial Inc New· Q1 2026 +696K Q1 2026
Sio Capital Management, LLC · New
Change +657K Date Q1 2026
Sio Capital Management, LLC New· Q1 2026 +657K Q1 2026
Peapod Lane Capital LLC · Reduced
Change −534K Date Q1 2026
Peapod Lane Capital LLC Reduced· Q1 2026 −534K Q1 2026
Ally Bridge Group (ny) LLC · New
Change +526K Date Q1 2026
Ally Bridge Group (ny) LLC New· Q1 2026 +526K Q1 2026
Prosight Management, LP · New
Change +516K Date Q1 2026
Prosight Management, LP New· Q1 2026 +516K Q1 2026
Jane Street Group, LLC · Added
Change +286K Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +286K Q1 2026
Two Sigma Advisers, LP · Exited
Change −265K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −265K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 53

Famous investor activity in AN2 Therapeutics, Inc. (ANTX)

AN2 Therapeutics, Inc. (ANTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Aziz Kabeer · Director Grant (A) 3K
Owned 59K ΔOwn +5.1% Trade date Jul 10, 2026 Filed date Jul 10, 2026
Aziz Kabeer Director Grant (A) 3K 59K +5.1% Jul 10, 2026 Jul 10, 2026
Marks Gilbert Lynn · Director Grant (A) 3K
Owned 82K ΔOwn +3.5% Trade date Jul 10, 2026 Filed date Jul 10, 2026
Marks Gilbert Lynn Director Grant (A) 3K 82K +3.5% Jul 10, 2026 Jul 10, 2026
Martin Patricia A. · Director Grant (A) 766
Owned 19K ΔOwn +4.2% Trade date Jul 10, 2026 Filed date Jul 10, 2026
Martin Patricia A. Director Grant (A) 766 19K +4.2% Jul 10, 2026 Jul 10, 2026
Eizen Joshua M. · Officer Sell −$25K
Price $4.17 Qty −6K Owned 207K ΔOwn −2.8% Trade date Jul 8, 2026 Filed date Jul 10, 2026
Eizen Joshua M. Officer Sell $4.17 −6K −$25K 207K −2.8% Jul 8, 2026 Jul 10, 2026
Williams Sarah Joanne · Officer Sell −$1K
Price $4.43 Qty −265 Owned 67K Trade date May 29, 2026 Filed date Jun 2, 2026
Williams Sarah Joanne Officer Sell $4.43 −265 −$1K 67K May 29, 2026 Jun 2, 2026
Aziz Kabeer · Director Grant (A) 4K
Owned 56K Trade date Apr 10, 2026 Filed date Apr 10, 2026
Aziz Kabeer Director Grant (A) 4K 56K Apr 10, 2026 Apr 10, 2026
Marks Gilbert Lynn · Director Grant (A) 4K
Owned 79K Trade date Apr 10, 2026 Filed date Apr 10, 2026
Marks Gilbert Lynn Director Grant (A) 4K 79K Apr 10, 2026 Apr 10, 2026
Martin Patricia A. · Director Grant (A) 1K
Owned 18K Trade date Apr 10, 2026 Filed date Apr 10, 2026
Martin Patricia A. Director Grant (A) 1K 18K Apr 10, 2026 Apr 10, 2026
Day Lucy · Officer 3 operations -222K
Owned 0 Trade date Mar 19, 2026 Filed date Mar 23, 2026
Day Lucy Officer 3 operations -222K 0 Mar 19, 2026 Mar 23, 2026
Day Lucy · Officer 3 operations 222K
Owned 74K Trade date Mar 19, 2026 Filed date Mar 23, 2026
Day Lucy Officer 3 operations 222K 74K Mar 19, 2026 Mar 23, 2026
Chanda Sanjay · Officer 3 operations -166K
Owned 0 Trade date Mar 19, 2026 Filed date Mar 23, 2026
Chanda Sanjay Officer 3 operations -166K 0 Mar 19, 2026 Mar 23, 2026
Chanda Sanjay · Officer 3 operations 166K
Owned 66K Trade date Mar 19, 2026 Filed date Mar 23, 2026
Chanda Sanjay Officer 3 operations 166K 66K Mar 19, 2026 Mar 23, 2026
Marks Gilbert Lynn · Director 3 operations -45K
Owned 0 Trade date Mar 19, 2026 Filed date Mar 23, 2026
Marks Gilbert Lynn Director 3 operations -45K 0 Mar 19, 2026 Mar 23, 2026
Marks Gilbert Lynn · Director 3 operations 45K
Owned 24K Trade date Mar 19, 2026 Filed date Mar 23, 2026
Marks Gilbert Lynn Director 3 operations 45K 24K Mar 19, 2026 Mar 23, 2026
Aziz Kabeer · Director 2 operations -44K
Owned 0 Trade date Mar 19, 2026 Filed date Mar 23, 2026
Aziz Kabeer Director 2 operations -44K 0 Mar 19, 2026 Mar 23, 2026
15 of 62
15 of 62 Sign in to continue to older insider transactions.

AN2 Therapeutics, Inc. (ANTX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ra Capital Management, L.P. 5.6M
% of shares outstanding 18.7% Filing date Feb 14, 2024
Ra Capital Management, L.P. 5.6M 18.7% Feb 14, 2024
Coastlands Capital Partners LP 2.8M
% of shares outstanding 9.3% Filing date Jun 4, 2025
Coastlands Capital Partners LP 2.8M 9.3% Jun 4, 2025
Tcg Crossover Gp I, LLC 2.7M
% of shares outstanding 9.0% Filing date Feb 9, 2024
Tcg Crossover Gp I, LLC 2.7M 9.0% Feb 9, 2024
Easom Eric 2.2M
% of shares outstanding 7.9% Filing date Feb 13, 2026
Easom Eric 2.2M 7.9% Feb 13, 2026
Adjuvant Global Health Technology Fund, L.P. 2.1M
% of shares outstanding 7.0% Filing date Feb 9, 2024
Adjuvant Global Health Technology Fund, L.P. 2.1M 7.0% Feb 9, 2024
Adjuvant Global Health Technology Fund, L.P. 2.0M
% of shares outstanding 6.7% Filing date Feb 28, 2025
Adjuvant Global Health Technology Fund, L.P. 2.0M 6.7% Feb 28, 2025
Citadel Advisors LLC 1.6M
% of shares outstanding 5.2% Filing date Feb 14, 2024
Citadel Advisors LLC 1.6M 5.2% Feb 14, 2024
Easom Eric 1.6M
% of shares outstanding 5.2% Filing date Feb 13, 2024
Easom Eric 1.6M 5.2% Feb 13, 2024
8 of 19

AN2 Therapeutics, Inc. (ANTX) ownership FAQ

Who owns ANTX?

53 reporting institutions disclosed ANTX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.